Vitamin B3 Doesn't Cut Skin Cancer Risk After Organ Transplant
(MedPage Today) -- Daily treatment with nicotinamide, an active water-soluble form of vitamin B3, failed to reduce the risk of non-melanoma skin cancer in solid-organ transplant recipients with a history of skin cancer, a phase III study in Australia...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Australia Health | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer | Study | Transplants | Vitamin B3 | Vitamins